These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

73 related articles for article (PubMed ID: 15451931)

  • 21. Impaired vasocontractile responses to adenosine in chorionic vessels of human term placenta from pregnant women with pre-existing and gestational diabetes.
    Razak AA; Leach L; Ralevic V
    Diab Vasc Dis Res; 2018 Nov; 15(6):528-540. PubMed ID: 30130976
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Cord blood telomere length, telomerase activity and inflammatory markers in pregnancies in women with diabetes or gestational diabetes.
    Cross JA; Temple RC; Hughes JC; Dozio NC; Brennan C; Stanley K; Murphy HR; Fowler D; Hughes DA; Sampson MJ
    Diabet Med; 2010 Nov; 27(11):1264-70. PubMed ID: 20950384
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Management of type 2 diabetes and gestational diabetes in pregnancy.
    Boinpally T; Jovanovic L
    Mt Sinai J Med; 2009 Jun; 76(3):269-80. PubMed ID: 19421970
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Maternal serum level of placental growth factor in diabetic pregnancies.
    Ong CY; Lao TT; Spencer K; Nicolaides KH
    J Reprod Med; 2004 Jun; 49(6):477-80. PubMed ID: 15283058
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Anti-islet Cell Antibodies in a Sample of Egyptian Females with Gestational Diabetes and its Relation to Development of Type 1 Diabetes Mellitus.
    Amer HM; Abd El Baky RS; Nasr MS; Hendawy LM; Ibrahim WA; Taha MO
    Curr Diabetes Rev; 2018; 14(4):389-394. PubMed ID: 28464768
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Maternal serum ferritin and hemoglobin values in patients with gestational diabetes mellitus.
    Gungor ES; Danisman N; Mollamahmutoglu L
    Saudi Med J; 2007 Mar; 28(3):478-80. PubMed ID: 17334491
    [No Abstract]   [Full Text] [Related]  

  • 27. The 0.1% of the population with glucokinase monogenic diabetes can be recognized by clinical characteristics in pregnancy: the Atlantic Diabetes in Pregnancy cohort.
    Chakera AJ; Spyer G; Vincent N; Ellard S; Hattersley AT; Dunne FP
    Diabetes Care; 2014; 37(5):1230-6. PubMed ID: 24550216
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Changes in plasma lipids and markers of oxidative stress in normal pregnancy and pregnancies complicated by diabetes.
    Toescu V; Nuttall SL; Martin U; Nightingale P; Kendall MJ; Brydon P; Dunne F
    Clin Sci (Lond); 2004 Jan; 106(1):93-8. PubMed ID: 12875648
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Gestational diabetes: the controversy continues.
    Holt RI
    Diabet Med; 2017 Jan; 34(1):7. PubMed ID: 27976429
    [No Abstract]   [Full Text] [Related]  

  • 30. Density distribution of erythrocytes in class A2 (insulin requiring) gestational diabetes.
    Lurie S
    Arch Gynecol Obstet; 1996; 258(2):65-8. PubMed ID: 8779612
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Assessment and management of pregnancies complicated by pregestational and gestational diabetes mellitus.
    Reece EA; Homko CJ
    J Assoc Acad Minor Phys; 1994; 5(3):87-97. PubMed ID: 7949826
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Optimal timing for postprandial glucose measurement in pregnant women with diabetes and a non-diabetic pregnant population evaluated by the Continuous Glucose Monitoring System (CGMS).
    Bühling KJ; Winkel T; Wolf C; Kurzidim B; Mahmoudi M; Wohlfarth K; Wäscher C; Schink T; Dudenhausen JW
    J Perinat Med; 2005; 33(2):125-31. PubMed ID: 15843262
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Maternal Diabetes, Large-for-Gestational-Age Births, and First Trimester Pregnancy-Associated Plasma Protein-A.
    Wells G; Bleicher K; Han X; McShane M; Chan YF; Bartlett A; White C; Lau SM
    J Clin Endocrinol Metab; 2015 Jun; 100(6):2372-9. PubMed ID: 25825946
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Predicting gestational diabetes: choosing the optimal early serum marker.
    Smirnakis KV; Plati A; Wolf M; Thadhani R; Ecker JL
    Am J Obstet Gynecol; 2007 Apr; 196(4):410.e1-6; discussion 410.e6-7. PubMed ID: 17403439
    [TBL] [Abstract][Full Text] [Related]  

  • 35. The effect of telemedicine on outcome and quality of life in pregnant women with diabetes.
    Dalfrà MG; Nicolucci A; Lapolla A;
    J Telemed Telecare; 2009; 15(5):238-42. PubMed ID: 19590029
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Very tight vs. tight control: what should be the criteria for pharmacologic therapy dose adjustment in diabetes in pregnancy? Evidence from randomized controlled trials.
    Caissutti C; Saccone G; Ciardulli A; Berghella V
    Acta Obstet Gynecol Scand; 2018 Mar; 97(3):235-247. PubMed ID: 29125636
    [TBL] [Abstract][Full Text] [Related]  

  • 37. A case of fulminant type 1 diabetes with graves' disease.
    Miura Y; Suzuki A; Sato I; Kato Y; Oiso Y
    Diabetes Care; 2002 Oct; 25(10):1894-5. PubMed ID: 12351508
    [No Abstract]   [Full Text] [Related]  

  • 38. [Criteria and diagnostic methods or evaluations of therapeutic quality for directing prevention of symptoms in diabetes].
    Tatoń J
    Pol Arch Med Wewn; 2001; 105 Suppl():277-86. PubMed ID: 12412258
    [No Abstract]   [Full Text] [Related]  

  • 39. Gestational diabetes mellitus (GDM) diagnosis, therapy and follow-up care: Practice Guideline of the German Diabetes Association(DDG) and the German Association for Gynaecologyand Obstetrics (DGGG).
    Kleinwechter H; Schäfer-Graf U; Bührer C; Hoesli I; Kainer F; Kautzky-Willer A; Pawlowski B; Schunck K; Somville T; Sorger M; ;
    Exp Clin Endocrinol Diabetes; 2014 Jul; 122(7):395-405. PubMed ID: 25014091
    [No Abstract]   [Full Text] [Related]  

  • 40. Infant of a diabetic mother: a preexisting disease?
    Verklan MT
    J Perinat Neonatal Nurs; 2014; 28(1):87-8. PubMed ID: 24476656
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 4.